More than six million treatments with AMARIS

Significant upward trend with 1.5 million TransPRK/SmartSurfACE treatments

The SCHWIND AMARIS product family proves to be a constant model for success in corneal surgery and continues to be in high demand worldwide.

Next Event

French Society of Ophthalmology
More events